ARCHIVES

Group trials need prioritization, review, NCI official says.

This article is from The Cancer Letter archive.

Vol. 29 No. 30 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

Study: Routine CT Not Needed In Detecting DLBCL Remissions

May 31, 2013

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

Black Teens At Higher Risk Of Tobacco Addiction.

February 2, 2001